Navigation Links
Callidus Biopharma Announces $4.6 million in Series A Financing to Pursue Orphan Disease Therapies
Date:5/14/2013

g IGF-2. For the first time, we have the ability to modify nearly any therapeutic enzyme so it will be effectively delivered to the lysosome, enabling it to reduce the accumulated substrate that causes these devastating diseases."

Dr. Barry Byrne , Director of the University of Florida Powell Center for Rare Disease Research and a leading authority on Pompe disease and related diseases, and a pioneer in developing new therapies to restore muscle function in Pompe and other inherited myopathies, noted, "Callidus' approach opens up a new avenue for improving drug targeting of enzyme replacement treatments for Lysosomal Storage Disorders.  Poor targeting has been a major hurdle for efficient delivery of ERTs.  This breakthrough technology has the potential to improve the efficacy, safety and dosing regimens for ERTs for these devastating diseases."

Walter Greenblatt & Associates (member FINRA, SIPC), a life-science focused investment bank, served as the exclusive financial advisor to Callidus Biopharma in the transaction.

About Callidus Biopharma, Inc.

Callidus Biopharma, Inc. (www.callidusbiopharma.com) is a development-stage biotechnology company focused on developing superior biologic drugs for rare and ultra-rare diseases. Specifically, the company is focused on discovering and developing best-in-class enzyme replacement therapies (ERTs) for lysosomal storage diseases (LSDs). Callidus' novel technology platform is based on attaching a form of the naturally occurring insulin-like growth factor 2 (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body.

Callidus Biopharma's therapeutics offer the potential to reduce significantly the amount of drug that needs to be infused, which translates to patient and medical benefits of better efficacy, shorter infusion times, reduced immun
'/>"/>

SOURCE Walter Greenblatt & Associates
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
2. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
3. PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013
4. Rutgers Business School and the Blanche and Irwin Lerner Center will explore trends and issues facing the biopharmaceutical industry at a healthcare symposium, Tuesday, April 30
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
7. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
8. Comparison of Biopharmaceutical Industry Between China and India 2013
9. TransCelerate BioPharma Inc. Grows, Strengthens Novel Effort to Accelerate Drug Development
10. Biopharmaceutical Companies Transform Clinical Trial Strategies for Success in Global Marketplace
11. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LEXINGTON, Mass. , Dec. 23, 2014 /PRNewswire/ ... GEVA ), a biopharmaceutical company developing therapeutic products ... European Medicines Agency (EMA) of the Marketing Authorization ... The EMA recently granted the company,s request for ... the EMA,s regulatory review time.   ...
(Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
(Date:12/24/2014)... 23, 2014 Tianyin Pharmaceutical Co., Inc. ... in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... announced that the Company achieved the Public Notice ... (GMP) certificate of TPI,s Qionglai Facility (QLF) from ... public notice period is a significant procedure of ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3Kim Foerster Joins Lockton Companies 2TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying women’s ... discounted prom dresses, most of which are priced under ... company, the promotion is valid until Jan. 22, 2015; ... UK market. , The prom dresses in this new ... A-line strapless, empire strapless chiffon, one shoulder, floor-length, V-neck ...
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Helen ... home in Woodland Hills, California after an 8 year ... away on Christmas Eve evening in her home in ... aggressive metastatic breast cancer. , As ... over forty years, she pioneered and championed many of ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- The risk ... the holidays, so you need to be extra cautious, ... Day, we see a significant increase in patients coming ... at the Suffolk County Volunteer Firefighters Burn Center of ... celebrations should be full of joy, but if not ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate ... Today, the business has introduced its new collection of ... promotion. , The new prom outfits are guaranteed to ... lover. They are specially designed for 2015. Anyone who ... should visit its website before Jan. 26, 2015, the ...
(Date:12/25/2014)... 2014 Residents at Abernethy ... showed their generous spirit by providing holiday gifts ... Parenting Network- Grandparents Raising Grandchildren program. , Following ... the largest Christmas tree on the campus of ... residents of the Abernethy Village Association (AVA). Each ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... February is Heart ... … while having fun, too. , ... Los Angeles (Vocus) January 25, 2010 -- Every year, over 40,000 American women die ... to be one of them! , , , , ,February is Heart Health Month. Self-care ...
... ... hablan de disparidades e instan a los grupos de socorro a que tengan en ... ... del pasado indica que probablemente las mujeres y los niños en Haití no estén ...
... Center at the University of California, San Diego and ... between county hospitals and private providers. Patients treated in ... patients treated in private facilities tend to receive radiation ... the journal Cancer on January 25. ...
... Children who are mixed-handed, or ambidextrous, are more likely ... childhood than right- or left-handed children, according to a ... . The researchers behind the study, from ... their findings may help teachers and health professionals to ...
... ... the Christian perspective, promote faith-formation. , ... (PRWEB) January 24, 2010 -- Witness to Hope Ministries, a nonprofit ... behavioral health practice in Beaver, PA in order to serve at-risk and special needs ...
... 24, 2010 When University of Utah scientists discovered a ... conducting plastic or polymer, no one could explain how it ... later, the Utah researchers have found these "random lasers" occur ... say such lasers may prove useful for diagnosing cancer. ...
Cached Medicine News:Health News:Save The Ta-Ta's ... And Your Ticker 2Health News:Save The Ta-Ta's ... And Your Ticker 3Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 2Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 3Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 4Health News:Study confirms prostate cancer is treated differently at county vs. private hospitals 2Health News:Mixed-handed children more likely to have mental health, language and scholastic problems 2Health News:Mixed-handed children more likely to have mental health, language and scholastic problems 3Health News:Christian Nonprofit and Behavioral Health Practice Team Up to Help Children 2Health News:How 'random' lasers work 2Health News:How 'random' lasers work 3Health News:How 'random' lasers work 4Health News:How 'random' lasers work 5
... flexible continuous monitoring, the M3 and M4 ... and neonatal patient care. M Series monitors ... includes a basic set of non-invasive parameters ... Optional Multi-Measurement Server extensions offer Mainstream or ...
... On-line Electronic Help (OLEH), an ... to critical anesthesia-related information. OLEH brings ... need it most right on ... care of the patient and ...
Compact networked patient monitors for flexible care....
... for flexible care settings., ,IntelliVue ... portability and measurement flexibility to match ... intermediate care environmentsat the patients side., ... in patient monitoring, IntelliVue has highly ...
Medicine Products: